About Instituto de Investigaciones Biomédicas
Clinical Trials at Instituto de Investigaciones Biomédicas
During the past decade, Instituto de Investigaciones Biomédicas conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Investigaciones Biomédicas"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Instituto de Investigaciones Biomédicas
According to Clinical.Site data, the most researched conditions in "Instituto de Investigaciones Biomédicas" are
"Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Instituto de Investigaciones Biomédicas" in a lesser frequency.
Clinical Trials Intervention Types at Instituto de Investigaciones Biomédicas
Most popular intervention types in "Instituto de Investigaciones Biomédicas" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Canakinumab" (1 trials), "Metformin" (1 trials), "Placebo" (1 trials), "glimepiride" (1 trials) and "glimepiride placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto de Investigaciones Biomédicas
The vast majority of trials in "Instituto de Investigaciones Biomédicas" are
2 trials for "All" genders.
Clinical Trials Status at Instituto de Investigaciones Biomédicas
Currently, there are NaN active trials in "Instituto de Investigaciones Biomédicas".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Instituto de Investigaciones Biomédicas,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Investigaciones Biomédicas, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".